Kinesio Taping With &Without Craniosacral Therapy in Pregnant Females With SIJ Dysfunction.

NCT ID: NCT05811325

Last Updated: 2023-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-11

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SIJ dysfunction adversely affects quality of life and causes functional impairment and disability. Although, K taping and craniosacral therapy were previously affective in treating SI joint dysfunction, the combined affects of these intervention have not been compared previously to K taping alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized controlled trial and have 30 pregnant women suffering from SIJH dysfunction. There is 2 groups and both have received treatment for 6 weeks. The data on pain is collected through VAS and the data on disability is collected through Oswestry Disability Index, and data on quality of life will be collected using SF-36. Measurements will be taken at the beginning of the study and at the end of the 4th week, at the completion of the study. Data will be analyzed using SPSS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sacral Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

kinesio taping without craniosacral therapy

This group received Kinesio taping for improvement in pain,disability and quality of life.

Group Type EXPERIMENTAL

kinesiotaping without craniosacral therapy

Intervention Type OTHER

The first treatment group will receive kinesio taping for 6 weeks atleast 4 times per week

kinesio taping group with craniosacral therapy

Group received kinesio Taping with craniosacral therapy for improvement in pain,disability and quality of life.

Group Type ACTIVE_COMPARATOR

kinesiotaping with craniosacral therapy

Intervention Type OTHER

The second treatment group will receive kinesio taping with craniosacral therapy for 6 weeks atleast 4 times per week with each session lasting for 60 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

kinesiotaping without craniosacral therapy

The first treatment group will receive kinesio taping for 6 weeks atleast 4 times per week

Intervention Type OTHER

kinesiotaping with craniosacral therapy

The second treatment group will receive kinesio taping with craniosacral therapy for 6 weeks atleast 4 times per week with each session lasting for 60 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 18-35
* pregnant females in 3rd trimester
* pregnant females with SIJ dysfunction

Exclusion Criteria

* high risk pregnancy
* pregnant females with hypermobility syndrome
* previous pelvic history
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

tahreem Masood

Role: PRINCIPAL_INVESTIGATOR

ripah international university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Hopital

Lahore, , Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR&AHS/22/0538

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.